Company Information
USD
19.52
- (3.2%)
NASDAQ:CLDX, CELLDEX THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
Address
53 Frontage Road
Suite 220, Perryville III Building
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Anthony S. Marucci
CEO/Co-Founder/Director/President
Mr. James J. Marino, J.D.,M.B.A.
Director
Mr. Harry H. Penner, Jr
Director
Ms. Karen L. Shoos
Chairman of the Board/Director
Mr. Herbert J. Conrad
Director
Mr. Keith L. Brownlie
Director
Ms. Cheryl L. Cohen
Director
Dr. Garry A. Neil, M.D.
Director
Dr. Rita I. Jain, M.D.
Director
Mr. Sam Martin
CFO/Chief Accounting Officer/Secretary/Senior VP/Treasurer
Dr. Ronald A. Pepin
Other Executive Officer/Senior VP
Dr. Tibor Keler, PhD
Chief Scientific Officer/Executive VP
Ms. Sarah Cavanaugh
Senior VP, Divisional
Mr. Richard M. Wright
Other Executive Officer/Senior VP
Dr. Diane C. Young, M.D.
Chief Medical Officer/Senior VP
Ms. Elizabeth Crowley
Other Executive Officer/Senior VP
Dr. Margo Heath-Chiozzi
Senior VP, Divisional
Mr. Freddy A. Jimenez
General Counsel/Senior VP
Mr. Herbert J. Conrad
Director
Ownership
Institution Holdings
FMR LLC
7,064,974 (12.638%)
FMR Inc
7,050,409 (12.612%)
Wellington Management Company LLP
6,476,561 (11.586%)
Wellington Management Group, LLP
6,476,561 (11.586%)
Fidelity Management & Research Company LLC
4,368,805 (7.815%)
BlackRock Inc
3,675,692 (6.575%)
Eventide Asset Management, LLC
3,630,013 (6.494%)
RTW INVESTMENTS, LLC
3,463,201 (6.195%)
Polar Capital Holdings PLC
3,135,871 (5.610%)
Vanguard Group Inc
3,046,331 (5.450%)
Funds Holdings
BB Biotech AG
1,900,000 (3.399%)
Eventide Healthcare & Life Sciences Fund
1,812,364 (3.242%)
Polar Capital Biotechnology Fund
1,750,000 (3.131%)
Vanguard US Total Market Shares ETF
1,721,283 (3.079%)
Vanguard Total Stock Market Index Fund
1,721,283 (3.079%)
SPDR® S&P Biotech ETF
1,389,938 (2.486%)
iShares Russell 2000 ETF
1,160,735 (2.076%)
Pictet - Biotech
1,127,124 (2.016%)
Fidelity Select Biotechnology Portfolio
973,000 (1.741%)
Vanguard Institutional Extnd Mkt Idx Tr
805,453 (1.441%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
